According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

The incidence of pancreatic adenocarcinoma increases across all age groups, whereas colorectal adenocarcinoma increases only among younger age groups.

Researchers from Heidelberg Pharma AG have presented a new antibody-drug conjugate (ADC) that shows promise for treating pancreatic ductal adenocarcinoma (PDAC). The ADC, called hRS7 ATAC, targets ...

A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the University of Michigan have ...

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...

Arvind Trindade, MD, discusses the background of a study investigating rates of pancreatic and colon cancer among younger patients.

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups.

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, ...

In the US, the incidence of pancreatic cancer is increasing in patients of all ages, and the incidence of colorectal cancer is increasing in patients aged 15-34 years.

Novocure (NVCR) announced that it will present additional results from the Phase 3 PANOVA-3 trial of its Tumor Treating Fields therapy for ...

KWES morning anchor Victor Lopez let viewers know that he is fighting stage 4 colon cancer. "I was diagnosed with ...